Phakellistatin 3

General Information


DRACP ID  DRACP02941

Peptide Name   Phakellistatin 3

Sequence  PFGPTIX

Sequence Length  7

UniProt ID  Not available

PubChem CID  10485551 

Origin  Phakellia carteri

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
P388 Mouse lymphoma Lymphoma ED50=0.33 μg/mL Not available Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  NCB: Pro1<--->X7

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=Photo-Trp

Chiral  L



Physicochemical Information


Formula  C31H44N6O7

Absent amino acids  ACDEHKLMNQRSVWY

Common amino acids  P

Mass  82992

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  2

Net charge  0

Boman Index  627

Hydrophobicity  42.86

Aliphatic Index  55.71

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28335479

Title  Phakellistatins: An Underwater Unsolved Puzzle

Doi 10.3390/md15030078

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.